|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Research Article |
1 Laboratoire de Régulations Cellulaires et Oncogénése
UMR146, Institut Curie Section de Recherche, Centre Universitaire Paris-Sud,
91405 Orsay, France
2 Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX,
UK
3 Laboratoire de Compartimentation et Dynamique Cellulaires UMR144, Institut
Curie Section de Recherche, 26 rue d'Ulm, 75248 Paris, France
* Author for correspondence (e-mail: Brigitte.Boyer{at}curie.u-psud.fr )
Accepted 12 April 2002
Cell dissociation and cell migration are the two main components of epithelium-mesenchyme transitions (EMT). We previously demonstrated that Ras is required for the accomplishment of both of these processes during the EGF-induced EMT of the NBT-II rat carcinoma cell line in vitro. In this study, we examined the downstream targets of Ras that are responsible for the dissociation and motility of NBT-II cells. Overexpression of activated forms of c-Raf and MEK1 (a component of the mitogen-activated protein kinase pathway, MAPK) led to cell dissociation, as inferred by the loss of desmosomes from the cell periphery. By contrast, active PI3K, RalA and RalB did not induce desmosome breakdown. The MEK1 inhibitor PD098059 inhibited EGF- and Ras-induced cell dispersion, whereas the PI3K inhibitor LY294002 had no effect. Accordingly, among the partial loss-of-function mutants of Ras (RasV12) that were used to distinguish between downstream targets of Ras, we found that the Raf-specific Ras mutants RasV12S35 and RasV12E38 induced cell dissociation. The PI3K- and RalGDS-activating Ras mutants had, in contrast, no effect on cell dispersion. However, MEK1 was unable to promote cell motility, whereas RasV12S35 and RasV12E38 induced cell migration, suggesting that another Ras effector was responsible for cell motility. We found that the small GTPase Rac is necessary for EGF-mediated cell dispersion since overexpression of a dominant-negative mutant of Rac1 (Rac1N17) inhibited EGF-induced NBT-II cell migration. All stimuli that promoted cell migration also induced Rac activation. Finally, coexpression of active Rac1 and active MEK1 induced the motility of NBT-II cells, suggesting that Ras mediates NBT-II cell scattering through the coordinate activation of Rac and the Raf/MAPK pathway.
Key words: EMT, Signal transduction, Cell dissociation, Cell motility
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
D. Zhang, T. A. LaFortune, S. Krishnamurthy, F. J. Esteva, M. Cristofanilli, P. Liu, A. Lucci, B. Singh, M.-C. Hung, G. N. Hortobagyi, et al. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer Clin. Cancer Res., November 1, 2009; 15(21): 6639 - 6648. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Arnoux, M. Nassour, A. L'Helgoualc'h, R. A. Hipskind, and P. Savagner Erk5 Controls Slug Expression and Keratinocyte Activation during Wound Healing Mol. Biol. Cell, November 1, 2008; 19(11): 4738 - 4749. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lozano, M. A. M. Frasa, K. Smolarczyk, U. G. Knaus, and V. M. M. Braga PAK is required for the disruption of E-cadherin adhesion by the small GTPase Rac J. Cell Sci., April 1, 2008; 121(7): 933 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mimeault and S. K. Batra Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies Ann. Onc., October 1, 2007; 18(10): 1605 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Nielsen-Preiss, M. P. Allen, M. Xu, D. A. Linseman, J. E. Pawlowski, R. J. Bouchard, B. C. Varnum, K. A. Heidenreich, and M. E. Wierman Adhesion-Related Kinase Induction of Migration Requires Phosphatidylinositol-3-Kinase and Ras Stimulation of Rac Activity in Immortalized Gonadotropin-Releasing Hormone Neuronal Cells Endocrinology, June 1, 2007; 148(6): 2806 - 2814. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pijnenborg, G. Dam-de Veen, N Kisters, B Delvoux, M van Engeland, J. Herman, and P. Groothuis RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer Ann. Onc., March 1, 2007; 18(3): 491 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sato, T. Yazawa, T. Suzuki, H. Shimoyamada, K. Okudela, M. Ikeda, K. Hamada, H. Yamada-Okabe, M. Yao, Y. Kubota, et al. Growth Regulation via Insulin-Like Growth Factor Binding Protein-4 and -2 in Association with Mutant K-ras in Lung Epithelia Am. J. Pathol., November 1, 2006; 169(5): 1550 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pozzi, S. Coffa, N. Bulus, W. Zhu, D. Chen, X. Chen, G. Mernaugh, Y. Su, S. Cai, A. Singh, et al. H-Ras, R-Ras, and TC21 Differentially Regulate Ureteric Bud Cell Branching Morphogenesis Mol. Biol. Cell, April 1, 2006; 17(4): 2046 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Andersen, J. Mejlvang, S. Mahmood, I. Gromova, P. Gromov, E. Lukanidin, M. Kriajevska, J. K. Mellon, and E. Tulchinsky Immediate and Delayed Effects of E-Cadherin Inhibition on Gene Regulation and Cell Motility in Human Epidermoid Carcinoma Cells Mol. Cell. Biol., October 15, 2005; 25(20): 9138 - 9150. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Valles, M. Beuvin, and B. Boyer Activation of Rac1 by Paxillin-Crk-DOCK180 Signaling Complex Is Antagonized by Rap1 in Migrating NBT-II Cells J. Biol. Chem., October 22, 2004; 279(43): 44490 - 44496. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mori, M. Shibanuma, and K. Nose Invasive Potential Induced under Long-Term Oxidative Stress in Mammary Epithelial Cells Cancer Res., October 15, 2004; 64(20): 7464 - 7472. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okudela, H. Hayashi, T. Ito, T. Yazawa, T. Suzuki, Y. Nakane, H. Sato, H. Ishi, X. KeQin, A. Masuda, et al. K-ras Gene Mutation Enhances Motility of Immortalized Airway Cells and Lung Adenocarcinoma Cells via Akt Activation: Possible Contribution to Non-Invasive Expansion of Lung Adenocarcinoma Am. J. Pathol., January 1, 2004; 164(1): 91 - 100. [Abstract] [Full Text] [PDF] |
||||